157
Views
7
CrossRef citations to date
0
Altmetric
Review Article

Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems

, , , &
Pages 645-651 | Received 08 Aug 2010, Accepted 08 Dec 2010, Published online: 28 Jan 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Tadashi Kondo. (2017) Current status of proteomics of soft tissue sarcomas. Expert Review of Proteomics 14:12, pages 1131-1140.
Read now
Kristian Bjøro. (2011) This month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:6, pages 643-644.
Read now

Articles from other publishers (5)

Dun‐Chang Mo, Xu Liu, Yu‐Jie Lv, Yan‐Qiu Qin & Gui‐Sheng Xie. (2019) Is monocyte‐to‐lymphocyte ratio the best systematic inflammatory biomarker for the prognosis of gastrointestinal stromal tumors?. Journal of Surgical Oncology 119:7, pages 1024-1025.
Crossref
Jian-Hong Zhong, Qing-Lian Zhong, Le-Qun Li & Hang Li. (2014) Adjuvant and chemopreventive therapies for resectable hepatocellular carcinoma: a literature review. Tumor Biology 35:10, pages 9459-9468.
Crossref
D. Kubota, T. Okubo, T. Saito, Y. Suehara, A. Yoshida, K. Kikuta, H. Tsuda, H. Katai, Y. Shimada, K. Kaneko, A. Kawai & T. Kondo. (2012) Validation Study on Pfetin and ATP-dependent RNA Helicase DDX39 as Prognostic Biomarkers in Gastrointestinal Stromal Tumour. Japanese Journal of Clinical Oncology 42:8, pages 730-741.
Crossref
Tadashi Kondo, Daisuke Kubota & Akira Kawai. (2012) Application of Proteomics to Soft Tissue Sarcomas. International Journal of Proteomics 2012, pages 1-15.
Crossref
Daisuke Kubota, Hajime Orita, Akihiko Yoshida, Masahiro Gotoh, Tatsuo Kanda, Hitoshi Tsuda, Tadashi Hasegawa, Hitoshi Katai, Yasuhiro Shimada, Kazuo Kaneko, Akira Kawai & Tadashi Kondo. (2011) Pfetin as a Prognostic Biomarker for Gastrointestinal Stromal Tumor: Validation Study in Multiple Clinical Facilities. Japanese Journal of Clinical Oncology 41:10, pages 1194-1202.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.